PKI - PerkinElmer, Inc.

NYSE - NYSE Delayed Price. Currency in USD
80.62
-0.26 (-0.32%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close80.88
Open81.40
Bid0.00 x 900
Ask0.00 x 1300
Day's Range79.40 - 82.17
52 Week Range70.74 - 98.33
Volume811,517
Avg. Volume703,649
Market Cap8.968B
Beta (3Y Monthly)1.47
PE Ratio (TTM)71.60
EPS (TTM)1.13
Earnings DateJan 23, 2019 - Jan 28, 2019
Forward Dividend & Yield0.28 (0.33%)
Ex-Dividend Date2019-01-17
1y Target Est91.50
Trade prices are not sourced from all markets
  • See what the IHS Markit Score report has to say about PerkinElmer Inc.
    Markit4 days ago

    See what the IHS Markit Score report has to say about PerkinElmer Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Goods sector is rising.

  • Should You Buy PerkinElmer, Inc. (PKI)?
    Insider Monkey6 days ago

    Should You Buy PerkinElmer, Inc. (PKI)?

    Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren’t very good. However, our research shows this not to be the case. In fact, when it comes to their very top picks collectively, they show a strong ability […]

  • Business Wire9 days ago

    PerkinElmer Appoints President & Chief Operating Officer

    PerkinElmer, Inc. (PKI), a global leader committed to innovating for a healthier world, today announced that its board of directors has named Prahlad Singh president and chief operating officer, effective January 1, 2019. In his expanded position, Dr. Singh will have responsibility for both the Discovery and Analytical Solutions (DAS) and Diagnostics operating divisions of the Company. This change is being made to better facilitate synergies across the businesses to identify incremental growth opportunities, create operating efficiencies, and most importantly, accelerate the pace of innovation across the Company.

  • Why PerkinElmer Inc’s (NYSE:PKI) CEO Pay Matters To You
    Simply Wall St.14 days ago

    Why PerkinElmer Inc’s (NYSE:PKI) CEO Pay Matters To You

    Rob Friel became the CEO of PerkinElmer Inc (NYSE:PKI) in 2008. First, this article will compare CEO compensation with compensation at other large companies. After that, we will consider the Read More...

  • PerkinElmer (PKI) Up 5.9% Since Last Earnings Report: Can It Continue?
    Zacks19 days ago

    PerkinElmer (PKI) Up 5.9% Since Last Earnings Report: Can It Continue?

    PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Stock Market News For Nov 27, 2018
    Zacks22 days ago

    Stock Market News For Nov 27, 2018

    Markets closed sharply higher on Monday after posting steep losses last week.

  • PerkinElmer's Vanadis NIPT CE Mark Boosts Prenatal Prospects
    Zacks22 days ago

    PerkinElmer's Vanadis NIPT CE Mark Boosts Prenatal Prospects

    PerkinElmer's (PKI) Vanadis NIPT is a more cost effective and non-invasive screening system compared to traditional ones.

  • Business Wire23 days ago

    PerkinElmer Receives CE-IVD Mark for Its Vanadis Fully Automated NIPT Platform

    PerkinElmer, Inc. (PKI), a global leader committed to innovating for a healthier world, today announced that its Vanadis® NIPT system has obtained CE-IVD mark for commercialization and distribution throughout Europe and other countries that accept CE marking. This non-invasive test provides screening results for trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome).

  • Business Wire27 days ago

    PerkinElmer to Present at 2018 Citi Global Healthcare Conference

    PerkinElmer, Inc. (PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 2018 Citi Global Healthcare Conference on Wednesday, December 5, 2018, at 11:45 a.m. ET at the Lotte New York Palace in New York City. Jamey Mock, PerkinElmer’s senior vice president and chief financial officer, will provide an overview of the Company and its strategic priorities.

  • Business Wirelast month

    PerkinElmer to Present at Evercore ISI HealthCONx Conference

    PerkinElmer, Inc. (PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 2018 Evercore ISI HealthCONx Conference on Thursday, November 29, at 10:15 a.m. ET at the Boston Harbor Hotel. Robert F. Friel, PerkinElmer’s chairman and chief executive officer, will provide an overview of the Company and its strategic priorities. A live audio webcast of the presentation will also be available on the Investors section of the Company's website at www.perkinelmer.com.

  • See what the IHS Markit Score report has to say about Perkinelmer Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about Perkinelmer Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Goods sector is rising.

  • GlobeNewswirelast month

    Market Trends Toward New Normal in PerkinElmer, Fortinet, Lincoln National, Hyatt Hotels, The New York Times, and DICK'S Sporting Goods — Emerging Consolidated Expectations, Analyst Ratings

    NEW YORK, Nov. 05, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of PKI earnings conference call or presentation 31-Oct-18 9:00pm GMT

    Q3 2018 PerkinElmer Inc Earnings Call

  • PerkinElmer (PKI) Misses on Q3 Earnings, Slashes EPS View
    Zacks2 months ago

    PerkinElmer (PKI) Misses on Q3 Earnings, Slashes EPS View

    Perkinelmer (PKI) gains from segmental performances in Q3; lowers 2018 EPS view.

  • PerkinElmer Inc (PKI) Q3 2018 Earnings Conference Call Transcript
    Motley Fool2 months ago

    PerkinElmer Inc (PKI) Q3 2018 Earnings Conference Call Transcript

    PKI earnings call for the period ending September 30, 2018.

  • PerkinElmer (PKI) Lags Q3 Earnings and Revenue Estimates
    Zacks2 months ago

    PerkinElmer (PKI) Lags Q3 Earnings and Revenue Estimates

    PerkinElmer (PKI) delivered earnings and revenue surprises of -2.17% and -0.02%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

  • MarketWatch2 months ago

    PerkinElmer shares sink on disappointing third-quarter earnings

    Shares of PerkinElmer Inc. sank in Wednesday's extended session after the diagnostics and life sciences research company reported quarterly results that fell short of Wall Street's expectations. PerkinElmer reported third-quarter earnings fell to $76.5 million, or 69 cents a share, from $81.1 million, or 82 cents a share, a year ago. On an adjusted basis, it would have earned 90 cents a share. Revenue increased 22% to $674.3 million. Analysts surveyed by FactSet had forecast earnings of 92 cents a share on revenue of $677 million. Shares slumped 8% after hours.

  • Associated Press2 months ago

    PerkinElmer: 3Q Earnings Snapshot

    The Waltham, Massachusetts-based company said it had net income of 69 cents per share. Earnings, adjusted for one-time gains and costs, came to 90 cents per share. The results missed Wall Street expectations. ...

  • Business Wire2 months ago

    PerkinElmer Announces Financial Results for the Third Quarter of 2018

    WALTHAM, Mass.-- -- GAAP revenue growth of 22% to $674.3 million; Core organic revenue growth of 7% GAAP earnings per share from continuing operations of $0.68; Adjusted earnings per share of $0.90, an increase of 23% PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today reported financial results for the third quarter ended September 30, 2018. The Company reported ...

  • Can BD Medical Drive Becton, Dickinson's (BDX) Q4 Earnings?
    Zacks2 months ago

    Can BD Medical Drive Becton, Dickinson's (BDX) Q4 Earnings?

    Becton, Dickinson (BDX) likely to gain from strong segmental contributions in fiscal Q4.

  • Business Wire2 months ago

    PerkinElmer Board Declares Quarterly Dividend

    The Board of Directors of PerkinElmer, Inc. , declared a regular quarterly dividend of $0.07 per share of common stock on October 24, 2018. This dividend is payable on February 8, 2019 to all shareholders of record at the close of business on January 18, 2019.

  • Can Diagnostic Revenues Drive PerkinElmer (PKI) Q3 Earnings?
    Zacks2 months ago

    Can Diagnostic Revenues Drive PerkinElmer (PKI) Q3 Earnings?

    PerkinElmer (PKI) likely to gain from strong segmental revenues in Q3; a raised earnings guidance for 2018 is promising.

  • See what the IHS Markit Score report has to say about Perkinelmer Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Perkinelmer Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Goods sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way.